The aim of the present study was to investigate the relationship between insomnia severity and the immunologic, neurotrophic, neuroendocrine, neuropeptide, and metabolic processes underlying MDD in a clinical sample of individuals with MDD. The gene discussed is NPS; the disease is insomnia measurement.